ADMA vs KIM · P/E 22, rev $238.9M vs P/E 27, rev $1.11B
ADMA Biologics Inc (ADMA) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported KIM revenue for 2026-06-30 was $1.11B. Net income was $318.2M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the ADMA and KIM stock pages for the full models.
Not investment advice.